This study showed that BIRC5, SLCO4A1, POPDC3, and HK2 were significantly downregulated in stage MS NB and affected the survival rate of children, indicating that the low expression of these four genes is a factor conducive to tumor regression. This evidence concerns the gene SLCO4A1 and neuroblastoma.